CTSU N1048: Phase 2/3 Trial of Neoadjuvant FOLFOX w. Selective Use of Combined Modality Chemotherapy v. Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w. Total Mesorectal Excision

June 29, 2018
https://clinicaltrials.gov/ct2/show/NCT01515787
Cancer - Colorectal
Principal Investigator: Ding Wang, MD
Cancer, Cancer Gastro, Rectal, Rectal Cancer, Advanced, Phase 2, Phase 3, Advanced Rectal Cancer, Low Anterior Resection, Total Mesorectal Excision, CTSU, FOLFOX
Open